EUVIMEDEUVIMED entdecken
Open Access

Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice

Joshua J Deppas, Brian F Kiesel, Jianxia Guo, Robert A Parise, D Andy Clump, David Z D'Argenio, Christopher J Bakkenist, Jan H Beumer

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04675-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Joshua J Deppas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA. Hauptthemen laut MEDLINE: Ataxia Telangiectasia Mutated Proteins, Mice, Inbred BALB C, Dose-Response Relationship, Drug. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ataxia Telangiectasia Mutated ProteinsMice, Inbred BALB CDose-Response Relationship, DrugAnimalsFemaleMiceTissue DistributionPyrazinesTandem Mass SpectrometryHumansPyrazolesNonlinear DynamicsAdministration, IntravenousIsoxazoles

Stichwörter der Autor:innen

ATR inhibitorBerzosertibPharmacokineticsPreclinicalProtein bindingTissue distribution

Substanzen

Ataxia Telangiectasia Mutated ProteinsberzosertibPyrazinesAtr protein, mousePyrazolesIsoxazoles

Autor:innen und Institutionen

  • Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA.
  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
  • Department of Radiation Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.
  • Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA. beumerj@gmail.com.

Förderung

  • NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Deppas, J. J., Kiesel, B. F., Guo, J., Parise, R. A., Clump, D. A., D'Argenio, D. Z., Bakkenist, C. J., & Beumer, J. H. (2024). Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04675-3

Vancouver

Deppas JJ, Kiesel BF, Guo J, Parise RA, Clump DA, D'Argenio DZ, et al. Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04675-3

BibTeX
@article{Deppas2024,
  author = {Deppas, Joshua J and Kiesel, Brian F and Guo, Jianxia and Parise, Robert A and Clump, D Andy and D'Argenio, David Z and Bakkenist, Christopher J and Beumer, Jan H},
  title = {Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04675-3}
}
Kostenlos starten →